Manufacture

We interview Johannes Khinast, CEO and Scientific Director of the Research Center for Pharmaceutical Engineering (RCPE), Graz, Austria.

Technology transfer is full of risks. But risks can be mitigated with the right strategy.

Suppliers of reagents and buffers need to adhere to quality systems.

Let’s reduce the impact of pharmaceutical effluent on the environment.

Are your capsids full, half full, or empty? We need better analytical techniques to find out.

Find out about the five top trends that will shape biopharma manufacture in 2021.

We catch up with Samsung Biologics about easing tech transfers and preparing plants for the future.

After years of speculation, we reveal what Brexit really means for pharma – so far.

And the winner of The Medicine Maker 2020 Innovation Awards is…

What is the single greatest challenge facing the cell and gene therapy industry in 2021?